Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record history shows the addition of revision v3.5.2 and the deletion of revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:25:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:39:19.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    New revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T19:58:34.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.4.2 entry, and the prior government funding notice and Revision: v3.4.1 entry were removed. These changes relate to page versioning and site notices rather than the trial data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T04:55:16.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and the page revision tag v3.4.1, replacing v3.4.0; no study data, eligibility, or results were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T05:34:08.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle and displays change highlights using green for additions and red for deletions, along with an updated revision label. No core study content, results, or critical details were modified; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-28T03:24:37.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.